Announcement on Resolutions of the 16th Session of the Ninth Board of Directors
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2017-034
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
9th 16th Board Resolution Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liability for the authenticity, accuracy and completeness of its contents.
1. Board Meeting
(I) The convening and convening of this board meeting complies with relevant laws, regulations and the company's "Articles of Association.
(II) 2017# On October 19, 29, the company issued the notice of the board meeting by fax, e-mail and personal delivery.
(III) 2017On October 30, the board meeting was held by means of communication voting.
(IV) 9directors who should attend this board meeting, 9 directors who actually attended the meeting, and 9 valid votes at the meeting.
Review of 2. Board Meeting(I) Passed "2017
Third Quarter Report"
After deliberation and voting, the Board of Directors passed "Company 2017Third Quarter Report".
Voting result: 9votes in favor, 0 votes against, 0 abstentions. The third quarter report of
company 2017can be found on the website of Shanghai Stock Exchange (www.sse.com.cn).
(II) passed the "Proposal on the General Election of the Board of Directors"The current board of directors was elected at the first extraordinary general meeting of shareholders in 2014 held on November 12, 2014
. The term of office of the board of directors is three years, and a general election is required. The company's largest shareholder, Jinhua Tongji State-owned Assets Investment Company, recommended Mr. Jiang Xiaomeng, Mr. Yu Jianhong, Mr. Liu Bo, and Mr. Zhang Guoping as candidates for the company's tenth board of directors; the current board of directors recommended: Mr. Du Zihong, Mr. Huang Sujian, Shi Ximin Mr., Mr. Huang Congyun, Mr. Sun Hongbin are candidates for the company's tenth board of directors, among them, Mr. Shi Ximin, Mr. Huang Conyun, and Mr. Sun Hongbin are candidates for independent directors (the candidates' resumes are attached); the above 9 persons will be submitted as candidates for the company's tenth board of directors to the first extraordinary general meeting of shareholders in 2017. The general meeting of shareholders will provide online voting, and the cumulative voting system will not be adopted to elect directors. Each director candidate will be proposed in the form of a single proposal. According to the company's "Articles of Association", the current directors will continue to perform their duties as directors until a new board of directors is elected by the general meeting of shareholders.
The three independent directors of the company expressed their independent opinions on this and agreed to the proposal on the change of the board of directors passed at the meeting. At the same time, they believed that the formation of the above resolutions complied with the relevant provisions of the Company Law and the Company's Articles of Association, and did not harm small and medium shareholders. interest.After deliberation and voting, the board of directors passed the "Proposal on the General Election of the Board of Directors."
Voting result: 9
votes in favor, 0 votes against, 0 abstentions.
(III) passed the "Proposal on Convening the First Extraordinary General Meeting of Shareholders in 2017"
. After deliberation and voting, the board of directors passed the proposal and agreed to issue a notice. The company's first extraordinary general meeting of shareholders in 2017 will be held on November 16, 2017to hold a general election for the board of directors and the board of supervisors of the company. Voting result of
: 9votes in favor, 0 votes against and 0 abstentions. For details of
, please refer to the Company's Notice on Convening the First Extraordinary General Meeting of Shareholders in 2017(P.2017 -037).
3. Internet Announcement Annex1
, Independent Director Opinions of the 9th Independent Director of the Company on the Above Related Matters.
2, Independent Director Candidate Statement.
3, Independent Director Nominee Statement.
hereby announcesZhejiang Jianfeng Group Co., Ltd.
Board of Directors
October 31, 2017Attached: Resume of Director Candidate
1
, Mr. Jiang Xiaomeng: 1964# born in November 117, master of Business Administration/Engineering, professor-level senior engineer, licensed pharmacist, expert enjoying special allowance of the State Council, young and middle-aged expert with outstanding contribution in Zhejiang Province, joined the work in December 1980, successively served as workshop director of Jinhua cement Plant, manager of enterprise management department of the company, general manager of Zhejiang Jianfeng Communication Cable Co., Ltd., general manager of Zhejiang Jianfeng Pharmaceutical Co., Ltd., deputy general manager and general manager of the company. He is currently the Chairman and Secretary of the Party Committee of the Company, concurrently serving: vice Chairman of the Board of Directors of Tianshili Holding Group Co., Ltd., Vice Chairman of Tianshili Pharmaceutical Group Co., Ltd., Director of Southern Cement Co., Ltd., Chairman of Zhejiang Jinhua Nanfang Jianfeng Cement Co., Ltd., Director of Jinhua Tongji State-owned Assets Investment Co., Ltd., Zhejiang Building Materials Industry Chairman, Vice President of Zhejiang Chamber of Commerce, Vice President of Zhejiang Entrepreneurs Association, Chairman of Jinhua Federation of Industry and Commerce, Chairman of Jinhua General Chamber of Jinhua Entrepreneurs Association. 2
, Mr. Du Zihong: 1939# born in December 121, senior economist, joined the work in December 1957, served as the director of Jinhua Cement Plant since 1983, and later served as the company's general manager, Chairman and Secretary of the Party Committee. He is currently a director of the company and concurrently serves as a director of Tianshili Holding Group Co., Ltd. and vice chairman of China Enterprise Management Research Association.3 , Mr. Yu Jianhong: born in October 125, 1966#, senior economist, engineer, EMBA, joined the work in September 1987, successively served as deputy director of the machine repair workshop of Jinhua cement factory, chief of technical department, deputy director and director of Jinsong cement factory, general manager of Jianfeng group Jinhua Jinma cement co., ltd., general manager of Zhejiang Jianfeng cement co., ltd., deputy general manager of the company, and currently the director and general manager of the company, part-time: Vice President of Zhejiang Cement Association.
4 , Mr. Huang Sujian: 1955# born in November 129, doctor of economics, researcher, worked in the Institute of Industrial Economics of the Chinese Academy of Social Sciences from February 1988 to April 2016, and served as the Deputy Director of the Institute of Industrial Economics of the Chinese Academy of Social Sciences. He is currently a director of the company, a researcher at the Institute of Industrial Economics of the Chinese Academy of Social Sciences, and the president of the China Enterprise Management Research Association. He is also an independent director of Inner Mongolia Yitai Coal Co., Ltd., an independent director of Wolong Electric Group Co., Ltd., and an independent director of Zhejiang China Commodity City Group Co., Ltd.
5, Mr. Liu Bo: 1974# born in November 133, bachelor's degree, lecturer, took part in the work in August 1997. He used to be a teacher of Jinhua Radio and Television University, deputy director of the student office, director and vice president of the party committee president's office, and deputy general manager of Jinhua Tongji State-owned Assets Investment Co., Ltd. The current legal representative of Jinhua Tongji State-owned Assets Investment Co., Ltd. and deputy general manager of Jinhua State-owned Assets Management Co., Ltd. 6
, Mr. Zhang Guoping: 1976# born in June 137, bachelor degree, economist, started work in March 1999, assistant to the general manager and deputy director of the transportation department, assistant to the general manager and deputy director of the transportation department, director of the transportation department, and assistant to the manager and director of the office of Jinhua urban and, manager of Science and Technology Information Department of Jinhua Public Transport Group Co., Ltd., Assistant General Manager of Jinhua Asset Management Co., Ltd., Deputy General Manager of Jinhua Asset Management Co., Ltd.7 , Mr. Shi Ximin: 1960# was born in June 141, Ph.D. in management (accounting), currently an independent director of the company, a professor at the School of Accounting of Zhejiang University of Finance and Economics, and concurrently an independent director of Wolong Real Estate Group Co., Ltd., Zhejiang Feida Environmental Protection Technology Co., Ltd., Zhejiang Jiangshan Chemical Co., Ltd., Haining China Leather City Co., Ltd.
8 , Mr. Huang Congyun: 1963# born in March 145, professor and doctoral supervisor, currently professor of the School of Materials Science and Engineering of Wuhan University of Technology, professor of the State Key Laboratory of Silicate Building Materials. Expert member of the National Cement Standardization Technical Committee, deputy director of the Expert Technical Committee of China Cement Grinding Aids Association. He is now an expert in the evaluation of the National Science and Technology Progress Award and the Technology Invention Award, and an expert in the evaluation of various funds in Hubei, Shandong, Chongqing and other provinces and cities. As "cement grinding aids and concrete admixture", "cement equipment technology" and "cement additives" magazine consultant. Member of the Hubei Provincial Committee of the Democratic National Construction Association, Chairman of the Committee of the Wuhan University of Technology of the Democratic National Construction Association. He is currently an independent director of the Company.
9, Mr. Sun Hongbin: 1966# Born in December 149, Doctor of Science, Distinguished Professor of "Changjiang Scholar" of the Ministry of Education. He has successively engaged in post-doctoral research in Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Aachen University of Technology in Germany and University of Florida in the United States, and engaged in new drug research in California Metabolex Company in the United States. He is currently an independent director of the Company, a professor, doctoral supervisor and director of the New Drug Research Center of China Pharmaceutical University, director of Jiangsu Provincial Key Laboratory of Metabolic Diseases, Deputy Director of State Key Laboratory of "Natural Drug Active Components and Efficacy", Member of Medicinal Chemistry Professional Committee of Chinese Pharmaceutical Association, Deputy Chairman of Medicinal Chemistry Professional Committee of Jiangsu Pharmaceutical Association, Member of Degree Evaluation Committee and Academic Committee of China Pharmaceutical University, Deputy Leader of the "Thirteenth Five-Year" Development Strategy Research "Pharmacology" Expert Group of the Medical Department of the National Fund Committee, National Technology Invention Award Meeting Review Expert, Honorary Jiangsu Weikair chairman, etc.
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11